{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:58:59Z","timestamp":1790312339852,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["3332025152"],"award-info":[{"award-number":["3332025152"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-026"],"award-info":[{"award-number":["2021-I2M-1-026"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.biomaterials.2026.124600","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:53:44Z","timestamp":1788188024000},"page":"124600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Self-sustaining ROS-responsive hydrogel enabled delivery of PROTAC\/Ce6 nanoparticles via PDT-Epigenetic protein degradation to amplify pyroptosis for enhanced cancer immunotherapy"],"prefix":"10.1016","volume":"337","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8163-099X","authenticated-orcid":false,"given":"Liming","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mong-Hsiu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingji","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4852-4124","authenticated-orcid":false,"given":"Feifei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonggao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6924-2177","authenticated-orcid":false,"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"33","key":"10.1016\/j.biomaterials.2026.124600_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202502940","article-title":"Spatiotemporal charging single-atom nanozymes activated pyroptosis for antitumor immunotherapy via bioorthogonal disruption of succination and reinvigorating T lymphocytes","volume":"37","author":"Niu","year":"2025","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124600_bib2","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","article-title":"Cancer biomarkers: emerging trends and clinical implications for personalized treatment","volume":"187","author":"Passaro","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41392-023-01521-5","article-title":"Immunotherapy in hematologic malignancies: achievements, challenges and future prospects","volume":"8","author":"Tang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124600_bib4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib5","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1038\/s41467-024-52577-y","article-title":"Tumor draining lymph nodes connected to cold triple-negative breast cancers are characterized by Th2-associated microenvironment","volume":"15","author":"Guo","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","article-title":"Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab."},{"issue":"8016","key":"10.1016\/j.biomaterials.2026.124600_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-024-07373-5","article-title":"ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D","volume":"630","author":"Du","year":"2024","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124600_bib9","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41590-023-01526-w","article-title":"Molecular mechanisms of gasdermin D pore-forming activity","volume":"24","author":"Devant","year":"2023","journal-title":"Nat. Immunol."},{"issue":"8013","key":"10.1016\/j.biomaterials.2026.124600_bib10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/s41586-024-07314-2","article-title":"Brain endothelial GSDMD activation mediates inflammatory BBB breakdown","volume":"629","author":"Wei","year":"2024","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124600_bib11","doi-asserted-by":"crossref","first-page":"15864","DOI":"10.1021\/acsnano.4c02947","article-title":"Celecoxib augments paclitaxel-induced immunogenic cell death in triple-negative breast cancer","volume":"18","author":"Qian","year":"2024","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124600_bib12","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.immuni.2024.04.021","article-title":"Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer","volume":"57","author":"De Sanctis","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ymthe.2022.09.001","article-title":"MAP7D2 reduces CD8(+) cytotoxic T lymphocyte infiltration through MYH9-HMGB1 axis in colorectal cancer","volume":"31","author":"Wu","year":"2023","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124600_bib14","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1021\/jacs.3c01231","article-title":"Photon-controlled pyroptosis activation (PhotoPyro): an emerging trigger for antitumor immune response","volume":"145","author":"Li","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"25","key":"10.1016\/j.biomaterials.2026.124600_bib15","doi-asserted-by":"crossref","first-page":"11326","DOI":"10.1021\/jacs.2c03256","article-title":"Photocatalytic superoxide radical generator that induces pyroptosis in cancer cells","volume":"144","author":"Yu","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2026.124600_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.biomaterials.2017.08.010","article-title":"Bcl-2 inhibitor uploaded upconversion nanophotosensitizers to overcome the photodynamic therapy resistance of cancer through adjuvant intervention strategy","volume":"144","author":"Liu","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124600_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.biopha.2016.11.093","article-title":"Photoactivated hypericin increases the expression of SOD-2 and makes MCF-7 cells resistant to photodynamic therapy","volume":"85","author":"Kimakova","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biomaterials.2026.124600_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120609","article-title":"Tumor-permeated bioinspired theranostic nanovehicle remodels tumor immunosuppression for cancer therapy","volume":"269","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"issue":"16","key":"10.1016\/j.biomaterials.2026.124600_bib19","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1039\/D0CS01370F","article-title":"Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies","volume":"50","author":"Xie","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124600_bib20","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ccell.2023.04.019","article-title":"YTHDF2 inhibition potentiates radiotherapy antitumor efficacy","volume":"41","author":"Wang","year":"2023","journal-title":"Cancer Cell"},{"issue":"7336","key":"10.1016\/j.biomaterials.2026.124600_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature09803","article-title":"HDACs link the DNA damage response, processing of double-strand breaks and autophagy","volume":"471","author":"Robert","year":"2011","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.biomaterials.2026.124600_bib22","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/j.cell.2024.06.012","article-title":"Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance","volume":"187","author":"Yu","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-021-01424-5","article-title":"The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis","volume":"20","author":"Drumond-Bock","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12974-024-03185-6","article-title":"Lactylation of histone by BRD4 regulates astrocyte polarization after experimental subarachnoid hemorrhage","volume":"21","author":"Zhang","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-025-01721-2","article-title":"BRD4 acts as a transcriptional repressor of RhoB to inhibit terminal erythropoiesis","volume":"18","author":"Chen","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124600_bib26","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100293","article-title":"BRD4 directs hematopoietic stem cell development and modulates macrophage inflammatory responses","volume":"38","author":"Dey","year":"2019","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124600_bib27","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.apsb.2022.02.009","article-title":"A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization","volume":"12","author":"Yang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54854-2","article-title":"MMP-2-triggered, mitochondria-targeted PROTAC-PDT therapy of breast cancer and brain metastases inhibition","volume":"15","author":"Tong","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-025-02542-y","article-title":"Employing epigenetic protein degradation techniques to block CCL5-mediated photodynamic therapy via a programmed delivery platform","volume":"11","author":"Yang","year":"2026","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124600_bib30","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1172\/JCI86437","article-title":"BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models","volume":"126","author":"Kagoya","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"21","key":"10.1016\/j.biomaterials.2026.124600_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202313460","article-title":"A PROTAC augmenter for photo-driven pyroptosis in breast cancer","volume":"36","author":"Huang","year":"2024","journal-title":"Adv. Mater."},{"issue":"6330","key":"10.1016\/j.biomaterials.2026.124600_bib32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.aam7340","article-title":"Waste disposal-An attractive strategy for cancer therapy","volume":"355","author":"Salami","year":"2017","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124600_bib33","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/anie.201507978","article-title":"Small-molecule PROTACS: new approaches to protein degradation","volume":"55","author":"Toure","year":"2016","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biomaterials.2026.124600_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112993","article-title":"PROTACs to address the challenges facing small molecule inhibitors","volume":"210","author":"Martin-Acosta","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124600_bib35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","article-title":"Targeted protein degradation for cancer therapy","volume":"25","author":"Hinterndorfer","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124600_bib36","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","article-title":"Targeted protein degradation: from mechanisms to clinic","volume":"25","author":"Tsai","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124600_bib37","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","article-title":"Advancing targeted protein degradation for cancer therapy","volume":"21","author":"Dale","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124600_bib38","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1021\/acs.jmedchem.1c02155","article-title":"In silico modeling and scoring of PROTAC-mediated ternary complex poses","volume":"65","author":"Liao","year":"2022","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124600_bib39","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.chembiol.2022.08.004","article-title":"Target protein localization and its impact on PROTAC-mediated degradation","volume":"29","author":"Simpson","year":"2022","journal-title":"Cell Chem. Biol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124600_bib40","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-024-02024-9","article-title":"New-generation advanced PROTACs as potential therapeutic agents in cancer therapy","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124600_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115037","article-title":"PROTACS: a technology with a gold rush-like atmosphere","volume":"247","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124600_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"49","key":"10.1016\/j.biomaterials.2026.124600_bib44","doi-asserted-by":"crossref","first-page":"22622","DOI":"10.1021\/jacs.2c09255","article-title":"Bridged proteolysis targeting chimera (PROTAC) enables degradation of undruggable targets","volume":"144","author":"Xiong","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib45","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1038\/s41467-025-60107-7","article-title":"Linker-free PROTACs efficiently induce the degradation of oncoproteins","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.biomaterials.2026.124600_bib46","doi-asserted-by":"crossref","first-page":"14277","DOI":"10.1021\/acs.jmedchem.4c01104","article-title":"Radioactive ADME demonstrates ARV-110's high druggability despite low oral bioavailability","volume":"67","author":"He","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2026.124600_bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-pharmtox-030624-110238","article-title":"PROTACs as therapeutic modalities for drug discovery in castration-resistant prostate cancer","volume":"65","author":"Wang","year":"2025","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"34","key":"10.1016\/j.biomaterials.2026.124600_bib48","doi-asserted-by":"crossref","first-page":"22780","DOI":"10.1021\/acsnano.4c06888","article-title":"Hybrid nanoparticle-hydrogel systems for drug delivery depots and other biomedical applications","volume":"18","author":"Choi","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124600_bib49","article-title":"Programmable hydrogels: frontiers in dynamic closed-loop systems, biomimetic synergy, and clinical translation","author":"Xiang","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"21","key":"10.1016\/j.biomaterials.2026.124600_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202314520","article-title":"Borophene based 3D extrusion printed nanocomposite hydrogel for antibacterial and controlled release application","volume":"34","author":"Das","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2026.124600_bib51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mattod.2023.03.006","article-title":"Hydrogel-enabled, local administration and combinatorial delivery of immunotherapies for cancer treatment","volume":"65","author":"Erfani","year":"2023","journal-title":"Mater. Today"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124600_bib52","article-title":"Ferritin-based nanocomposite hydrogel promotes tumor penetration and enhances cancer chemoimmunotherapy","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"41","key":"10.1016\/j.biomaterials.2026.124600_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202403910","article-title":"Gemcitabine\u2010loaded injectable hydrogel for localized breast cancer immunotherapy","volume":"34","author":"Barough","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124600_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202511828","article-title":"Biopolymer hydrogels for adaptive remodeling of the tumor microenvironment to improve cancer immunotherapy","volume":"36","author":"Feng","year":"2026","journal-title":"Adv. Funct. Mater."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124600_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/gels11050370","article-title":"Dynamic boronate ester based hydrogel with enhanced mechanical properties and multi-stimuli-triggered release for tissue repair and antioxidant therapy","volume":"11","author":"Liu","year":"2025","journal-title":"Gels"},{"issue":"35","key":"10.1016\/j.biomaterials.2026.124600_bib56","article-title":"Recent developments in nanoparticle-hydrogel hybrid materials for controlled release","volume":"12","author":"Fan","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124600_bib57","doi-asserted-by":"crossref","first-page":"9536","DOI":"10.1021\/acsnano.7b05465","article-title":"Molecular-targeted immunotherapeutic strategy for melanoma via dual-targeting nanoparticles delivering small interfering RNA to tumor-associated macrophages","volume":"11","author":"Qian","year":"2017","journal-title":"ACS Nano"},{"issue":"48","key":"10.1016\/j.biomaterials.2026.124600_bib58","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1002\/anie.200903112","article-title":"Biomimetic nanocarrier for direct cytosolic drug delivery","volume":"48","author":"Zhang","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2026.124600_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101864","article-title":"In situ phagocyte-mediated deep tumor penetration assisted by ApoA-1 mimetic peptide-modified silicasome","volume":"50","author":"Wang","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2026.124600_bib60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.biomaterials.2016.05.008","article-title":"Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy","volume":"98","author":"Qian","year":"2016","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124600_bib61","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1021\/nn400683s","article-title":"Hybrid melittin cytolytic peptide-driven ultrasmall lipid nanoparticles block melanoma growth","volume":"7","author":"Huang","year":"2013","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0915-9","article-title":"BRD4 and Cancer: going beyond transcriptional regulation","volume":"17","author":"Donati","year":"2018","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124600_bib63","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03521-9","article-title":"An immune activator encapsulating PD-L1 siRNA for augmented immune checkpoint blockade immunotherapy through Zn2+ overload triggered pyroptosis","volume":"23","author":"Gong","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124600_bib64","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1039\/C8BM00899J","article-title":"Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy","volume":"6","author":"Yang","year":"2018","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biomaterials.2026.124600_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115394","article-title":"Near-infrared light-triggered degradable hyaluronic acid hydrogel for on-demand drug release and combined chemo-photodynamic therapy","volume":"229","author":"Xu","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"28","key":"10.1016\/j.biomaterials.2026.124600_bib66","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1002\/anie.201402189","article-title":"Conjugated-polyelectrolyte-based polyprodrug: targeted and image-guided photodynamic and chemotherapy with on-demand drug release upon irradiation with a single light source","volume":"53","author":"Yuan","year":"2014","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biomaterials.2026.124600_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123544","article-title":"Disrupting tumor homeostasis with an autoamplificatory nanoinducer to augment pyroptosis for efficient immunotherapy","volume":"324","author":"Zhang","year":"2026","journal-title":"Biomaterials"},{"issue":"17","key":"10.1016\/j.biomaterials.2026.124600_bib68","article-title":"A dual\u2010bioresponsive drug\u2010delivery depot for combination of epigenetic modulation and immune checkpoint blockade","volume":"31","author":"Ruan","year":"2019","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124600_bib69","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/acsnano.7b08152","article-title":"Core\u2013shell microneedle gel for self-regulated insulin delivery","volume":"12","author":"Wang","year":"2018","journal-title":"ACS Nano"},{"issue":"43","key":"10.1016\/j.biomaterials.2026.124600_bib70","article-title":"Immunostimulant in situ hydrogel improves synergetic radioimmunotherapy of malignant glioblastoma relapse post\u2010resection","volume":"32","author":"Sun","year":"2022","journal-title":"Adv. Funct. Mater."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:05:22Z","timestamp":1790309122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226006241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":70,"alternative-id":["S0142961226006241"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124600","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-sustaining ROS-responsive hydrogel enabled delivery of PROTAC\/Ce6 nanoparticles via PDT-Epigenetic protein degradation to amplify pyroptosis for enhanced cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124600"}}